Accordingly, inhibition of lipid synthesis in Treg cells leads to decreased PD-1 expression concomitant with enhanced PI3K–AKT signaling and IFN-γ production, and these effects sensitize B16F10 melanoma to anti-PD-1 treatment [92]. The gene discussed is PDCD1; the disease is melanoma.